as on September 18, 2025 at 4:01 pm IST
Market Cap
₹4,360.92 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
41.83
Return on capital employed (ROCE)
0Industry PE ratio
42.21
Beta (LTM)
1.68
P/B Ratio
0.91
Dividend Yield
0PEG Ratio
1.86
Quarterly Earnings Growth YOY
-130.18
EPS (TTM)
0.21
Sector
Pharmaceuticals
Book Value
371.91
Technical Analysis
Bullish
View Technical Analysis
as on September 18, 2025 at 4:01 pm IST
Dishman Carbogen Amcis Ltd in the last 5 years
Lowest (-599.35x)
March 22, 2023
Today (41.83x)
September 17, 2025
Industry (42.21x)
September 17, 2025
Highest (1374.29x)
June 11, 2025
Today’s Price to Earnings Ratio: 41.83x
Compare market cap, revenue, PE, and other key metrics of Dishman Carbogen Amcis Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 4,360.92 | 13.96% | 0.68 | 3 | 2,711 | |
NA | 323.06 | 12.17% | 0.00 | 10 | 150 | |
BUY | 11,519.78 | 5.09% | 0.00 | 485 | 2,386 | |
NA | 1,315.39 | 2290.77% | 0.00 | 9 | 32 | |
NA | 836.28 | -5.52% | 0.61 | 21 | 368 |
Search interest for Dishman Carbogen Amcis Ltd Stock has increased by 234% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:234% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd’s net profit jumped 130.18% since last year same period to ₹23.41Cr in the Q1 2025-2026. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated -45.67% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 per share on 15 May 2019 - translating a dividend yield of 0.07%.
Read More about DividendsCheck stock indices that include Dishman Carbogen Amcis Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 690.01 Cr → 732.8 Cr (in ₹), with an average increase of 3.0% per quarter
Best in 1 Year
In the last 1 year, DCAL has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 1 year, DCAL stock has moved up by 43.7%
Best in 3 Years
In the last 3 years, DCAL has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 1.06% to 1.07% in Jun 2025 quarter
FII Holding Up
Foreign Institutions have increased holdings from 9.49% to 9.93% in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.32% of holdings in Jun 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 29.93% to 29.47% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 43.09 Cr → 23.41 Cr (in ₹), with an average decrease of 45.7% per quarter
Organisation | Dishman Carbogen Amcis Ltd |
Headquarters | Gujarat |
Industry | Pharmaceuticals |
CEO | Janmejay R Vyas |
E-voting on shares | Click here to vote |
Dishman Carbogen Amcis Ltd share price today stands at ₹286.45 as on at the close of the market. Dishman Carbogen Amcis Ltd share today touched a day high of ₹288.8 and a low of ₹275.9.
Dishman Carbogen Amcis Ltd touched a 52 week high of ₹307.98 and a 52 week low of ₹161.21. Dishman Carbogen Amcis Ltd share price today i.e. is closed at ₹286.45, which is -6.99% down from its 52 week high and 77.69% up from its 52 week low.
Dishman Carbogen Amcis Ltd market capitalisation is ₹4,360.92 Cr as on .
To buy Dishman Carbogen Amcis Ltd shares, you need to follow these steps:
Dishman Carbogen Amcis Ltd trading volume is 5.83L as on . This means that 5.83L shares of Dishman Carbogen Amcis Ltd were bought and sold on the stock market during today's trading session.